A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
Clinical trial NCT04175613 · COMPLETED
Trial details
- NCT number
- NCT04175613
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-20
- Primary completion
- 2025-10-30
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.